AS
SAGE

Altshuler Shaham’s Sage Therapeutics SAGE Stock Holding History

Altshuler Shaham’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,403
Closed -$105K – 721
2021
Q1 		$105K Buy
+1,403
New +$115K ﹤0.01% 215
2020
Q2 		– Sell
-200
Closed -$6K – 535
2020
Q1 		$6K Sell
200
-1,163
-85% -$67.3K ﹤0.01% 339
2019
Q4 		$98K Buy
1,363
+200
+17% +$24.6K ﹤0.01% 179
2019
Q3 		$166K Buy
1,163
+49
+4% +$8.2K 0.01% 170
2019
Q2 		$204K Sell
1,114
-5,673
-84% -$968K 0.01% 115
2019
Q1 		$1.08M Buy
6,787
+5,268
+347% +$763K 0.05% 85
2018
Q4 		$146K Sell
1,519
-31
-2% -$3.55K 0.01% 113
2018
Q3 		$219K Hold
1,550
– – 0.01% 106
2018
Q2 		$243K Hold
1,550
– – 0.02% 101
2018
Q1 		$250K Buy
+1,550
New +$263K 0.03% 106

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return